Drugs / Dextenza Ophthalmic Insert
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04539548 | Sep 2020 → Dec 2023 | cataract | Ocular Therapeutix, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dextenza Ophthalmic Insert | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04539548 ↗ |
| Route | Other | “0.4mg insert for intracanalicular use” NCT04539548 ↗ |